{
  "url": "https://finance.yahoo.com/quote/OLMA/",
  "title": "Olema Pharmaceuticals, Inc. (OLMA) Stock Price, News, Quote & History - Yahoo Finance",
  "text": "Olema Pharmaceuticals, Inc. (OLMA) - Previous Close 25.65 - Open 25.40 - Bid 18.93 x 100 - Ask 32.10 x 200 - Day's Range 24.95 - 27.59 - 52 Week Range 2.86 - 36.26 - Volume 1,465,184 - Avg. Volume 3,860,078 - Market Cap (intraday) 2.095B - Beta (5Y Monthly) 1.92 - PE Ratio (TTM) -- - EPS (TTM) -1.76 - Earnings Date Nov 10, 2025 - Forward Dividend & Yield -- - Ex-Dividend Date -- - 1y Target Est 45.90 Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer; OPERA-01, the pivotal Phase 3 clinical trial of palazestrant as a monotherapy in second/third-line ER+/HER2- metastatic breast cancer; and palazestrant with CDK4/6 inhibitors palbociclib and ribociclib, a phosphatidylinositol 3 kinase alpha (PI3Ka) inhibitor alpelisib, and with an mTOR inhibitor everolimus that is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive human epidermal growth factor receptor 2-negative breast cancer. It also develops OP-3136, an orally-available small molecule that potently and selectively inhibits KAT6 for patients with ER+/HER2- metastatic breast cancer and other cancers which is in Phase 1 clinical trial. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California. olema.comRecent News: OLMA View MorePerformance Overview: OLMA Trailing total returns as of 2/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) . YTD Return 1-Year Return 3-Year Return 5-Year Return Earnings Trends: OLMA View MoreAnalyst Insights: OLMA View MoreStatistics: OLMA View MoreValuation Measures Market Cap 2.06B Enterprise Value 1.73B Trailing P/E -- Forward P/E -- PEG Ratio (5yr expected) -- Price/Sales (ttm) -- Price/Book (mrq) 6.81 Enterprise Value/Revenue -- Enterprise Value/EBITDA -- Financial Highlights Profitability and Income Statement Profit Margin 0.00% Return on Assets (ttm) -34.41% Return on Equity (ttm) -59.22% Revenue (ttm) -- Net Income Avi to Common (ttm) -149.96M Diluted EPS (ttm) -1.76 Balance Sheet and Cash Flow Total Cash (mrq) 328.96M Total Debt/Equity (mrq) 1.46% Levered Free Cash Flow (ttm) -71.39M Compare To: OLMA Select to analyze similar companies using key performance metrics; select up to 4 stocks. Company Insights: OLMA Fair Value Dividend Score Hiring Score Insider Sentiment Score Research Reports: OLMA View MoreDaily – Vickers Top Buyers & Sellers for 01/16/2026 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions. Daily – Vickers Top Buyers & Sellers for 12/24/2025 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions. Daily – Vickers Top Buyers & Sellers for 06/15/2022 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions. Daily – Vickers Top Buyers & Sellers for 12/03/2021 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions."
}